Reported Nov 9, 2016 · Ongoing
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia,…
Actavis Laboratories, FL, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Actavis Laboratories, FL, Inc. · 4955 Orange Dr · Davie, FL · 33314-3902
Is this the product you have?
- Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only
- Manufactured byArrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta
- Distributed byActavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30
- Lot codes and dates
- Lot #: 1136091A
- Incorrectly Labeled Exp03/18
- Amount recalled
- 15,984 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Actavis Laboratories, FL, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.